The Effect of Citalopram Pretreatment on Neuronal Responses to Neuropsychological Tasks in Normal Volunteers: An fMRI Study
The DOI matches its Crossref record; 86 of the 88 references it cites were found in a registry or an index.
Abstract
Changes in serotonin neurotransmission have also been implicated in the etiology and treatment of impulse control disorders, depression, and anxiety. We have investigated the effect of enhancing serotonin function on fundamental brain processes that we have proposed are abnormal in these disorders. In all, 12 male volunteers received citalopram (7.5 mg intravenously) and placebo pretreatment in a single-blind crossover design before undertaking Go/No-go, Loss/No-loss, and covert (aversive) face emotion recognition tasks during functional magnetic resonance imaging (fMRI). Blood oxygenation level dependent responses were analyzed using Statistical Parametric Mapping (SPM2). The tasks activated prefrontal and subcortical regions generally consistent with literature with lateral orbitofrontal cortex (BA47) common to the three tasks. Citalopram pretreatment enhanced the right BA47 responses to the No-go condition, but attenuated this response to aversive faces. Attenuations were seen following citalopram in the medial orbitofrontal (BA11) responses to the No-go and No-loss (ie relative reward compared with Loss) conditions. The right amygdala response to aversive faces was attenuated by citalopram. These results support the involvement of serotonin in modulating basic processes involved in psychiatric disorders but argue for a process-specific, rather than general effect. The technique of combining drug challenge with fMRI (pharmacoMRI) has promise for investigating human psychiatric disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ADs were shown to have an early effect on the neural networks dysfunctional in depression and proposed as the neural ‘scaffolding’ for the negative bias formation”
From Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment (2021) · cites this paper as Del-Ben et al. 2005
In the citing paper
“changes in response to emotionally salient information were also observed across other relevant structures, such as medial prefrontal cortex (mPFC), insula, ventral striatum, thalamus, orbito-frontal cortex and dlPFC”
From Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment (2021) · cites this paper as Del-Ben et al. 2005
In the citing paper
“Most consistent and robust reports regarded the amygdala and the ACC”
From Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment (2021) · cites this paper as Del-Ben et al. 2005
In the citing paper
“Consistent effects have not been found in other brain regions although in 2 studies viewing negative emotions had opposite effects on right VLPFC of lowering 5-HT function with ATD and increasing it with citalopram (leading to increased and decreased activation respectively) (Del-Ben et al., 2005;Fusar-Poli et al., 2007).”
From Affective Cognition and its Disruption in Mood Disorders (2011) · cites this paper as Del-Ben et al., 2005
In the citing paper
“Studies acutely enhancing 5-HT function with citalopram have found decreased amygdala responses to negative compared with neutral faces (Anderson et al., 2007;Del-Ben et al., 2005;Murphy et al., 2009a) but increased activation comparing faces (emotional and neutral) and a sensorimotor control task (Bigos et al., 2008).”
From Affective Cognition and its Disruption in Mood Disorders (2011) · cites this paper as Del-Ben et al., 2005
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
The expression of the emotions in man and animals.
Darwin, C. (1872) · J. Murray eBooks · doi:10.1037/10001-000 · Cited by 11,657
Insensitivity to future consequences following damage to human prefrontal cortex
Bechara, A., Damasio, A. R., Damasio, H., & Anderson, S. W. (1994) · Cognition · doi:10.1016/0010-0277(94)90018-3 · Cited by 6,128 · cited 1×
“…in recognition and processing of reward and punishment stimuli, with some findings suggesting an anatomical division of its functions with lateral areas associated with loss/punishment and medial areas more with reward (Bechara et al, 1994; O'Doherty et al, 2001; Elliott et al, 2003).”
BackgroundEkman, P. (1976) · Medical Entomology and Zoology · Cited by 4,345
Functional neuroanatomy of emotion: A meta-analysis of emotion activation studies in PET and fMRI
Phan, K. L., Wager, T., Taylor, S. F., & Liberzon, I. (2002) · NeuroImage · doi:10.1006/nimg.2002.1087 · Cited by 3,502 · cited 1×
“…to visualize the functional neuroanatomy of specific components of emotional processing such as response to reward and punishment (Elliott et al, 2000b), fear conditioning (Morris et al, 2001), emotion recognition (for a review, see Phan et al, 2002), and impulse control (Casey et al, 1997).”
BackgroundA differential neural response in the human amygdala to fearful and happy facial expressions
Morris, J. S., Frith, C. D., Perrett, D. I., Rowland, D., Young, A. W., Calder, A. J., & Dolan, R. J. (1996) · Nature · doi:10.1038/383812a0 · Cited by 2,013 · cited 3×
“…relating to fearful faces (eg Morris et al, 1996; Hariri et al, 2000; Phillips et al, 2001), a response that is lateralized in some studies (eg Morris et al, 1996), possibly relating to different rates of habituation with one study finding faster habituation in the right than left amygdala to…”
BackgroundMethodAbstract reward and punishment representations in the human orbitofrontal cortex
O'Doherty, J., Kringelbach, M. L., Rolls, E. T., Hornak, J., & Andrews, C. (2001) · Nature Neuroscience · doi:10.1038/82959 · Cited by 2,003
KRINGELBACH, M. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.03.006 · Cited by 1,977 · cited 2×
“Other studies have also reported medial OFC responses to rewarding stimuli (see Kringelbach and Rolls, 2004, for a review).”
BackgroundStop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans
Aron, A. R., Fletcher, P. C., Bullmore, E. T., Sahakian, B. J., & Robbins, T. W. (2003) · Nature Neuroscience · doi:10.1038/nn1003 · Cited by 1,771 · cited 2×
“The lateral orbitofrontal cortex (OFC), particularly on the right, is a common area activated by No-go compared with Go conditions in these studies and appears to be specifically involved in the inhibition of responses (Aron et al, 2003; Rubia et al, 2003; Menon et al, 2001; Liddle et al, 2001).”
Background
Research works printed but not linked: 3
- First MB, Spitzer RL, Gibbon M, Williams JBW (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. Biometrics Research, New York State Psychiatric Institute: (SCID-I/NP) New York.
- Longe O, Deakin JFW, Elliott R (2003). Anticipating reinforcement in Unipolar Depression Presented at the ninth International Conference on Functional Mapping of the Human Brain, June 19–22, 2003, New York, NY. Available on CD-Rom in NeuroImage 19 (Volume 2).
- Talairach J, Tournoux P (1988). Coplanar Stereotactic Atlas of the Human Brain. George Thieme Verlag: Stuttgart.
Cited by
Emotional perception: Meta-analyses of face and natural scene processing
Sabatinelli, D., Fortune, E. E., Li, Q., Siddiqui, A., Krafft, C., Oliver, W. T., Beck, S., & Jeffries, J. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.10.011 · Cited by 665
How do antidepressants work? New perspectives for refining future treatment approaches
Harmer, C. J., Duman, R. S., & Cowen, P. J. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30015-9 · Cited by 616
Eagle, D. M., Bari, A., & Robbins, T. W. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1127-6 · Cited by 548
“Citalopram enhanced the response of the lateral orbitofrontal cortex (BA47) to the no-go condition, whereas it attenuated the response to the no-go condition in the medial orbitofrontal (BA11), using fMRI (Del-Ben et al. 2005).”
MethodResponse inhibition and psychopathology: A meta-analysis of go/no-go task performance
Wright, L., Lipszyc, J., Dupuis, A., Thayapararajah, S. W., & Schachar, R. (2014) · Journal of Abnormal Psychology · doi:10.1037/a0036295 · Cited by 360
The suicidal mind and brain: A review of neuropsychological and neuroimaging studies
Jollant, F., Lawrence, N. L., Olié, E., Guillaume, S., & Courtet, P. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.556200 · Cited by 363
Affective Cognition and its Disruption in Mood Disorders
Elliott, R., Zahn, R., Deakin, J. F. W., & Anderson, I. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.77 · Cited by 330
“Consistent effects have not been found in other brain regions although in 2 studies viewing negative emotions had opposite effects on right VLPFC of lowering 5-HT function with ATD and increasing it with citalopram (leading to increased and decreased activation respectively) (Del-Ben et al., 2005; Fusar-Poli et al., 2…”
BackgroundSelf-citationA critical review of sex differences in decision-making tasks: Focus on the Iowa Gambling Task
van den Bos, R., Homberg, J., & de Visser, L. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.10.002 · Cited by 325
Bari, A., Theobald, D. E., Caprioli, D., Mar, A. C., Aidoo-Micah, A., Dalley, J. W., & Robbins, T. W. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.233 · Cited by 325
“…to negative stimuli (Browning et al, 2007; Chamberlain et al, 2006), punishment prediction (Cools et al, 2008b) and the activation of brain areas involved in error detection and processing of aversive events (Anderson et al, 2007; Del-Ben et al, 2005; Evers et al, 2005; McKie et al, 2005).”
BackgroundDeakin, J. F. W., Lees, J., McKie, S., Hallak, J. E. C., Williams, S. R., & Dursun, S. M. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.37 · Cited by 311
Self-citationTest-retest reliability of evoked BOLD signals from a cognitive-emotive fMRI test battery.
Plichta, M. M., Schwarz, A. J., Grimm, O., Morgen, K., Mier, D., Haddad, L., Gerdes, A. B. M., Sauer, C., Tost, H., Esslinger, C., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.01.129 · Cited by 287
“However, the magnitude of the BOLD signal change and the t-values (at both voxel and ROI-level) observed here are consistent with those reported using similar facial affect or emotive tasks that have been sufficient for the detection of changes in intervention studies (Del-Ben et al., 2005; Harmer et al., 2006; Murphy…”
ResultNeuropsychological mechanism underlying antidepressant effect: a systematic meta-analysis
Ma, Y. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.24 · Cited by 270
Reward and the serotonergic system
Kranz, G. S., Kasper, S., & Lanzenberger, R. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.01.036 · Cited by 267
Effect of a single dose of citalopram on amygdala response to emotional faces
Murphy, S. E., Norbury, R., O'Sullivan, U., Cowen, P. J., & Harmer, C. J. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.056093 · Cited by 255
“10 However, interpretation of the clinical implications of this finding is problematic since intravenous SSRI administration is not typically used in the treatment of patients.”
Browning, M., Holmes, E. A., & Harmer, C. J. (2010) · Cognitive, Affective, & Behavioral Neuroscience · doi:10.3758/cabn.10.1.8 · Cited by 247
“…amygdala activation to negative stimuli in both clinical (Fu et al., 2004; Sheline et al., 2001) and nonclinical (Arce, Simmons, Lovero, Stein, & Paulus, 2008; Del-Ben et al., 2005; Harmer, Mackay, Reid, Cowen, & Goodwin, 2006; Murphy, Norbury, O’Sullivan, Cowen, & Harmer, 2009) populations.”
Lateral prefrontal cortex mediates the cognitive modification of attentional bias
Browning, M., Holmes, E. A., Murphy, S. E., Goodwin, G. M., & Harmer, C. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.10.031 · Cited by 236
Neuromodulation of reward‐based learning and decision making in human aging
Eppinger, B., Hämmerer, D., & Li, S. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06230.x · Cited by 234
Serotonin and emotional processing: does it help explain antidepressant drug action?
Harmer, C. J. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.036 · Cited by 219
Winstanley, C. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01323.x · Cited by 218
“This observation fits with the fact that, regarding the effects of acute administration of serotonergic drugs, no significant effects have been reported on any behavioural test of impulsivity in healthy volunteers (Table 3A) (Hart et al., 1991; Del-Ben et al., 2005; Chamberlain et al., 2006; 2007; Wingen et al., 2007;…”
BackgroundResultNeural circuitry of impaired emotion regulation in substance use disorders
Wilcox, C. E., Pommy, J. M., & Adinoff, B. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15060710 · Cited by 213
“Selective serotonin reuptake inhibitors (SSRIs) and benzodiazepines dampen amygdala, insula (96–98), and lOFC (97, 99) activity and are useful in the treatment of disorders of negative affect without substance disorders but not particularly in the treatment of substance disorders (11).”
Effects of MDMA on sociability and neural response to social threat and social reward
Bedi, G., Phan, K. L., Angstadt, M., & de Wit, H. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1635-z · Cited by 206
“These statistical thresholds have recently been applied to fMRI studies of amygdala-striatum function (Del-Ben et al. 2005; Hariri et al. 2002; McBride et al. 2006).”
Escitalopram effects on insula and amygdala BOLD activation during emotional processing
Arce, E., Simmons, A. N., Lovero, K. L., Stein, M. B., & Paulus, M. P. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1004-8 · Cited by 198
“Although several studies have used pharmaco-fMRI to assess the neural correlates of certain antidepressant agents (e.g., Chen et al. 2007; Del-Ben et al. 2005; Fu et al. 2007; Harmer et al. 2006; Rose et al. 2006; Sheline et al. 2001; Vollm et al. 2006), to our knowledge, this is the first study to…”
BackgroundIdentifying Functional Neuroimaging Biomarkers of Bipolar Disorder: Toward DSM-V
Phillips, M. L., & Vieta, E. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm060 · Cited by 196
Rubia, K., Cubillo, A., Smith, A. B., Woolley, J., Heyman, I., & Brammer, M. J. (2010) · Human Brain Mapping · doi:10.1002/hbm.20864 · Cited by 192
“In healthy volunteers, SSRIs as well as the antidepressant serotonin agonist Mirtazapine have shown to enhance right inferior prefrontal activation during the go/no-go task [Andersen et al., 2002; Del-Ben et al., 2005; Vollm et al., 2006].”
BackgroundHarmer, C. J., & Cowen, P. J. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0407 · Cited by 183
Burghardt, N. S., Bush, D. E. A., McEwen, B. S., & LeDoux, J. E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.023 · Cited by 179
An Update on the Role of Serotonin and its Interplay with Dopamine for Reward
Fischer, A. G., & Ullsperger, M. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00484 · Cited by 176
“, 2016) has likewise received considerable empirical support (Rogers et al., 2002; Cools et al., 2005; Del-Ben et al., 2005; Roiser et al., 2006; Tanaka et al., 2007; Seymour et al., 2012), while other studies support both punishment as well as reward processing (McCabe et al.”
ResultDunham, J. S., Deakin, J. F. W., Miyajima, F., Payton, A., & Toro, C. T. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.03.008 · Cited by 172
Self-citationNeuropharmacology of performance monitoring
Jocham, G., & Ullsperger, M. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.08.011 · Cited by 172
Anderberg, R. H., Richard, J. E., Hansson, C., Nissbrandt, H., Bergquist, F., & Skibicka, K. P. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.11.021 · Cited by 170
“, 2000) and can enhance amygdala activity in healthy umans (Del-Ben et al., 2005; McKie et al., 2005) and exacerbate the xpression of anxiety (Grillon et al.”
Serotonin and decision making processes
Homberg, J. R. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.06.001 · Cited by 167
Cognitive control in alcohol use disorder: deficits and clinical relevance
Wilcox, C. E., Dekonenko, C. J., Mayer, A. R., Bogenschutz, M. P., & Turner, J. A. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0054 · Cited by 166
fMRI predictors of treatment outcome in pediatric anxiety disorders
McClure, E. B., Adler, A., Monk, C. S., Cameron, J., Smith, S., Nelson, E. E., Leibenluft, E., Ernst, M., & Pine, D. S. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0542-9 · Cited by 165
“Effective treatments appear to alter these atypical patterns, in that, they produce significant decreases in amygdala activity in anxious and MDD adults, as do pharmacological challenges in healthy adults (Kilts et al. 2006; Fu et al. 2004; Sheline et al. 2001; Del-Ben et al. 2005; Furmark et al. 2002, 2005; Harmer et…”
BackgroundThe CREB1-BDNF-NTRK2 Pathway in Depression: Multiple Gene-Cognition-Environment Interactions
Juhasz, G., Dunham, J. S., McKie, S., Thomas, E., Downey, D., Chase, D., Lloyd-Williams, K., Toth, Z. G., Platt, H., Mekli, K., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.11.019 · Cited by 159
Self-citationNeuroimaging in anxiety disorders
Holzschneider, K., & Mulert, C. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.4/kholzschneider · Cited by 146
Oxytocin׳s role in anxiety: A critical appraisal
MacDonald, K., & Feifel, D. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.025 · Cited by 139
Multiple Modes of Impulsivity in Parkinson's Disease
Nombela, C., Rittman, T., Robbins, T. W., & Rowe, J. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085747 · Cited by 134
“However, in the introduction, we drew attention to the fact that these two tests can be differentiated from selective neurochemical dissociations in studies of animals and healthy humans, contrasting serotonergic and noradrenergic functions [1,12,14,71].”
BackgroundCitalopram modulation of neuronal responses to aversive face emotions: a functional MRI study
Anderson, I. M., Del-Ben, C. M., Mckie, S., Richardson, P., Williams, S. R., Elliott, R., & William Deakin, J. F. (2007) · NeuroReport · doi:10.1097/wnr.0b013e3282742115 · Cited by 129
“Sixty minutes after the end of the infusion, they received the covert face emotion recognition task together with two other neuropsychological tasks (reported elsewhere [10]).”
BackgroundMethodSelf-citationGodlewska, B. R., & Harmer, C. J. (2021) · Psychopharmacology · doi:10.1007/s00213-019-05448-0 · Cited by 123
Bhagwagar, Z., & Cowen, P. J. (2008) · Psychological Medicine · doi:10.1017/s0033291707001250 · Cited by 124
Efficacy markers in depression
Harmer, C. J., Cowen, P. J., & Goodwin, G. M. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110367722 · Cited by 122
“…prediction, Bigos et al. (2008) reported increased amygdala responses to fear with 20mg i.v. citalopram in healthy volunteers, but three other studies using more clinically relevant doses of this drug have found the opposite effect (Anderson et al., 2007; Del-Ben et al., 2005; Murphy et al., 2009).”
ResultThe neuroscience of sadness: A multidisciplinary synthesis and collaborative review
Arias, J. A., Williams, C., Raghvani, R., Aghajani, M., Baez, S., Belzung, C., Booij, L., Busatto, G., Chiarella, J., Fu, C. H., et al. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.01.006 · Cited by 119
“of emotional processing are thought to be relevant to decision-making in complex situations (Del-Ben et al., 2005; Harmer, Mackay, Reid, Cowen, & Goodwin, 2006; Norbury, Mackay, Cowen, Goodwin, & Harmer, 2007), a process known to be disturbed in MDD (Bell and D’Zurilla, 2009; Lee et al.”
van der Veen, F. M., Evers, E. A. T., Deutz, N. E. P., & Schmitt, J. A. J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301212 · Cited by 118
“The effects of ATD on amygdala activation are in line with findings of several other studies reporting sensitivity of the amygdala to serotonergic manipulations (eg Sheline et al, 2001; Fu et al, 2004; Del-Ben et al, 2005).”
ResultSelective serotonin reuptake inhibition modulates response inhibition in Parkinson’s disease
Ye, Z., Altena, E., Nombela, C., Housden, C. R., Maxwell, H., Rittman, T., Huddleston, C., Rae, C. L., Regenthal, R., Sahakian, B. J., et al. (2014) · Brain · doi:10.1093/brain/awu032 · Cited by 118
Windischberger, C., Lanzenberger, R., Holik, A., Spindelegger, C., Stein, P., Moser, U., Gerstl, F., Fink, M., Moser, E., & Kasper, S. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.10.013 · Cited by 114
Völlm, B., Richardson, P., McKie, S., Elliott, R., Deakin, J. F. W., & Anderson, I. M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04571.x · Cited by 106
Self-citationThe Modulatory Role of Serotonin on Human Impulsive Aggression
da Cunha‐Bang, S., & Knudsen, G. M. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.05.016 · Cited by 114
“findings; some studies show increased amygdala reactivity (80-83) whereas other studies find decreased amygdala reactivity (84, 85) after SSRI intervention.”
BackgroundAmygdala activation and symptom dimensions in obsessive-compulsive disorder
Via, E., Cardoner, N., Pujol, J., Alonso, P., López-Solà, M., Real, E., Contreras-Rodríguez, O., Deus, J., Segalàs, C., Menchón, J. M., et al. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.123364 · Cited by 101
Burghardt, N. S., & Bauer, E. P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.05.050 · Cited by 125
Improving response inhibition systems in frontotemporal dementia with citalopram
Hughes, L. E., Rittman, T., Regenthal, R., Robbins, T. W., & Rowe, J. B. (2015) · Brain · doi:10.1093/brain/awv133 · Cited by 100
“For example, in humans and animals, serotonergic agonists enhance prefrontal responses during inhibition (Anderson et al., 2002; Del-Ben et al., 2005; Vollm et al., 2006), whilst depleting serotonin im- pairs the ability to withhold a response (Harrison et al., 1999; Eagle et al., 2009) and reduces…”
BackgroundRubia, K., Cubillo, A., Woolley, J., Brammer, M. J., & Smith, A. (2011) · Human Brain Mapping · doi:10.1002/hbm.21048 · Cited by 98
“Acute SSRI administration has been shown to upregulate prefrontal brain regions during cognitive control tasks [Del-Ben et al., 2005; Vollm et al., 2005].”
BackgroundNeurobiological Pathways Linking Socioeconomic Position and Health
Gianaros, P. J., & Manuck, S. B. (2010) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181e1a23c · Cited by 98
Skandali, N., Rowe, J. B., Voon, V., Deakin, J. B., Cardinal, R. N., Cormack, F., Passamonti, L., Bevan-Jones, W. R., Regenthal, R., Chamberlain, S. R., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0229-z · Cited by 89
Self-citationLinking neuroscience with modern concepts of impulse control disorders in Parkinson's disease
Napier, T. C., Corvol, J., Grace, A. A., Roitman, J. D., Rowe, J. B., Voon, V., & Strafella, A. P. (2014) · Movement Disorders · doi:10.1002/mds.26068 · Cited by 99
Human 5-HT Transporter Availability Predicts Amygdala Reactivity In Vivo
Rhodes, R. A., Murthy, N. V., Dresner, M. A., Selvaraj, S., Stavrakakis, N., Babar, S., Cowen, P. J., & Grasby, P. M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1175-07.2007 · Cited by 93
“In a single intravenous infusion, or after 7 d of oral treatment, SSRIs attenuate the amygdala response to negative emotional faces in healthy volunteers (Del-Ben et al., 2005; Harmer et al., 2006), whereas 8 weeks of treatment with an SSRI attenuates amygdala activity in response to negative emotional faces in depres…”
BackgroundThe Neurochemistry of Fairness: Clarifying the Link between Serotonin and Prosocial Behavior
Crockett, M. J. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04506.x · Cited by 93
Affect and Financial Decision-Making: How Neuroscience Can Inform Market Participants
Peterson, R. L. (2007) · Journal of Behavioral Finance · doi:10.1080/15427560701377448 · Cited by 113
Epperson, C. N., Amin, Z., Ruparel, K., Gur, R., & Loughead, J. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.07.007 · Cited by 91
Xu, P., Peng, S., Luo, Y., & Gong, G. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.05.023 · Cited by 109
Schmidt, A., Kometer, M., Bachmann, R. F., Seifritz, E., & Vollenweider, F. X. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2811-0 · Cited by 103
“2003) may be partly due to an increased activity in the FG (Del-Ben et al. 2005).”
BackgroundKing, G. R., Ernst, T., Deng, W., Stenger, A., Gonzales, R. M. K., Nakama, H., & Chang, L. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4148-11.2011 · Cited by 89
“The superior frontal gyrus is involved in behavioral planning (Meister et al., 2004; Del-Ben et al., 2005; Kübler et al., 2006), while the middle frontal gyrus is involved in behavioral inhibition (Bernal and Altman, 2009).”
BackgroundAcute serotonin and dopamine depletion improves attentional control: findings from the Stroop task
Scholes, K. E., Harrison, B. J., O'Neill, B. V., Leung, S., Croft, R. J., Pipingas, A., Phan, K. L., & Nathan, P. J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301262 · Cited by 86
“Similarly, it has been found that increased serotonergic function can increase premature responses in a behavioral inhibition task in healthy humans (Del-Ben et al, 2005).”
BackgroundBall, T., Derix, J., Wentlandt, J., Wieckhorst, B., Speck, O., Schulze‐Bonhage, A., & Mutschler, I. (2009) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2009.02.022 · Cited by 97
Serotonin: modulator of a drive to withdraw.
Tops, M., Russo, S., Boksem, M. A. S., & Tucker, D. M. (2009) · Brain and Cognition · doi:10.1016/j.bandc.2009.03.009 · Cited by 86
“sponse inhibition trials (Del-Ben et al., 2005; Rubia et al., 2005; Völlm et al., 2006), but opposite results were reported in response”
ResultEmotional memory in depersonalization disorder: a functional MRI study.
Medford, N., Brierley, B., Brammer, M., Bullmore, E. T., David, A. S., & Phillips, M. L. (2006) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2006.05.007 · Cited by 84
“There is some evidence that SSRI antidepressants may reduce the BOLD response to emotional material (e.g. Fu et al., 2004; Del-Ben et al., 2005), while lamotrigine may have mood-stabilising properties which might influence response to such stimuli.”
Obeso, I., Wilkinson, L., & Jahanshahi, M. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2793-x · Cited by 94
“Imaging studies have established that manipulation of the serotonergic system alters orbitofrontal activation in no Go trials (e.g. Del-Ben et al. 2005).”
BackgroundMarsh, R., Horga, G., Parashar, N., Wang, Z., Peterson, B. S., & Simpson, H. B. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.02.004 · Cited by 79
“Importantly, most prior fMRI studies of cognitive control and conflict processing in OCD recruited medicated patients (8,13,16), complicating comparison with our data, because SSRIs can alter activation of fronto-striatal circuits on various fMRI tasks (49).”
Iidaka, T., Ozaki, N., Matsumoto, A., Nogawa, J., Kinoshita, Y., Suzuki, T., Iwata, N., Yamamoto, Y., Okada, T., & Sadato, N. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5261-04.2005 · Cited by 80
“A significant negative correlation between HA and amygdaloid activity may imply that enhanced 5-HT function in those with a high HA score reduced neural response in the limbic region in the C/C group (Del-Ben et al., 2005).”
BackgroundSimmons, A. N., Arce, E., Lovero, K. L., Stein, M. B., & Paulus, M. P. (2009) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990149 · Cited by 80
“Although these effects are not consistent as others have found that acute SSRI administration has been associated with decreased activation during affective image processing (Takahashi et al. 2005) and during a go/no-go task (Del-Ben et al. 2005).”
Brem, S., Hauser, T. U., Iannaccone, R., Brandeis, D., Drechsler, R., & Walitza, S. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0813-z · Cited by 79
Scoriels, L., Jones, P. B., & Sahakian, B. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.011 · Cited by 85
“Tests of facial emotion recognition are sensitive to serotonergic modulation (Harmer et al., 2004), and pharmacological fMRI experiments indicate that selective serotonin reuptake inhibitors (Del-Ben et al., 2005; Murphy et al., 2009) modulate amygdala response to emotional faces.”
BackgroundAntidepressants in healthy subjects: What are the psychotropic/psychological effects?
Serretti, A., Calati, R., Goracci, A., Simplicio, M. C. D., Castrogiovanni, P., & Ronchi, D. D. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.11.009 · Cited by 88
Single-dose serotonergic stimulation shows widespread effects on functional brain connectivity
Klaassens, B. L., van Gorsel, H. C., Khalili-Mahani, N., van der Grond, J., Wyman, B. T., Whitcher, B., Rombouts, S. A. R. B., & van Gerven, J. M. A. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.08.012 · Cited by 76
“In task-related fMRI paradigms it was shown that acute neural changes take place in the limbic system and prefrontal circuitry (Bruhl et al., 2010; Del-Ben et al., 2005; Murphy et al., 2009; Outhred et al., 2013).”
BackgroundSerotonergic and dopaminergic modulation of attentional processes
Boulougouris, V., & Tsaltas, E. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00925-4 · Cited by 83
Response inhibition and serotonin in autism: a functional MRI study using acute tryptophan depletion
Daly, E., Ecker, C., Hallahan, B., Deeley, Q., Craig, M., Murphy, C., Johnston, P., Spain, D., Gillan, N., Gudbrandsen, M., et al. (2014) · Brain · doi:10.1093/brain/awu178 · Cited by 73
“…combining functional MRI and the modulation of serotonin levels in healthy controls report brain activation changes in frontal cortex and striatum when performing the Go/No-Go inhibition task (Anderson et al., 2002; Del-Ben et al., 2005; Rubia et al., 2005; Vollm et al., 2006; Lamar et al., 2009).”
MethodAssessing human 5-HT function in vivo with pharmacoMRI
Anderson, I. M., McKie, S., Elliott, R., Williams, S., & Deakin, J. F. W. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.029 · Cited by 82
Self-citationGruber, O., Tost, H., Henseler, I., Schmael, C., Scherk, H., Ende, G., Ruf, M., Falkai, P., & Rietschel, M. (2010) · Human Brain Mapping · doi:10.1002/hbm.20849 · Cited by 72
“Both SSRI antidepressant and antipsychotic medication has been found to be associated with decreased amygdala activation [Del-Ben et al., 2005; Harmer et al., 2006; Takahashi et al., 2005], i.e. it cannot explain the amygdala hyperactivation found in our patients.”
BackgroundRecent insights into the neurobiology of impulsivity
Mitchell, M. R., & Potenza, M. N. (2014) · Current Addiction Reports · doi:10.1007/s40429-014-0037-4 · Cited by 70
Strawn, J. R., Wehry, A. M., DelBello, M. P., Rynn, M. A., & Strakowski, S. (2012) · Depression and Anxiety · doi:10.1002/da.21913 · Cited by 68
“To this end, administration of the SSRI, citalopram, and its senantiomer, escitalopram, both attenuate right amygdala responses to aversive faces[53;54] and reduce activation within the parahippocampal cortex to emotionally significant stimuli.”
BackgroundYe, Z., Rae, C. L., Nombela, C., Ham, T., Rittman, T., Jones, P. S., Rodríguez, P. V., Coyle‐Gilchrist, I., Regenthal, R., Altena, E., et al. (2016) · Human Brain Mapping · doi:10.1002/hbm.23087 · Cited by 68
“Although the effects of both drugs are associated with common frontostriatal circuits [Chamberlain et al., 2009; Del-Ben et al., 2005; Macoveanu et al., 2013], we suggest that the distinct clinical models for atomoxotine and citalopram reflect different roles of noradrenaline and serotonin in inhibitory control [Eagle…”
BackgroundWessa, M., & Lois, G. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150416224801 · Cited by 67
“In a series of studies, investigating the effect of SSRI intake on BOLD responses to emotional and neutral stimuli in healthy, never-depressed participants, decreased amygdala activity in response to aversive stimuli has been observed relatively consistently [6-12].”
BackgroundMethodOuthred, T., Hawkshead, B. E., Wager, T. D., Das, P., Malhi, G. S., & Kemp, A. H. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.07.010 · Cited by 72
Di Simplicio, M., Norbury, R., Reinecke, A., & Harmer, C. J. (2014) · Psychological Medicine · doi:10.1017/s0033291713000731 · Cited by 65
“Amygdala response to negative versus positive facial expressions is typically decreased after single-dose (Del-Ben et al. 2005; Bigos et al. 2008; Murphy et al. 2009; Rawlings et al. 2010) or 7-day (Harmer et al.”
BackgroundMapping the developmental pathways of child conduct problems through the neurobiology of empathy
Moul, C., Hawes, D. J., & Dadds, M. R. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.03.016 · Cited by 76
Terburg, D., Syal, S., Rosenberger, L. A., Heany, S. J., Phillips, N. J., Gericke, N., Stein, D. J., & van Honk, J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.183 · Cited by 74
“Acute SSRI administration has been shown to increase amygdala reactivity in tasks that required explicit evaluation of threatening facial expression (Bigos et al, 2008) but generally reduces amygdala reactivity to unattended facial expressions of threat (Del-Ben et al, 2005; Murphy et al, 2009).”
BackgroundPinkham, A. E., Gur, R. E., & Gur, R. C. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.7.807 · Cited by 66
Sustained attention and serotonin: a pharmaco‐fMRI study
Wingen, M., Kuypers, K. P. C., van de Ven, V., Formisano, E., & Ramaekers, J. G. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.923 · Cited by 66
“Another study used the SSRI citalopram in a withinsubject fMRI design and demonstrated effects of serotonin on brain areas involved in several neuropsychological tasks, despite little behavioral changes due to a ceiling effect (Del Ben et al., 2005).”
MethodA neurocognitive model for understanding treatment action in depression
Warren, M. B., Pringle, A., & Harmer, C. J. (2015) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2014.0213 · Cited by 66
A single dose of mirtazapine modulates neural responses to emotional faces in healthy people
Rawlings, N. B., Norbury, R., Cowen, P. J., & Harmer, C. J. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1983-8 · Cited by 65
“Previous studies have shown attenuation in the right amygdala– hippocampal region and specifically the amygdala during the presentation of aversive facial expressions in healthy volunteers after both treatment with acute citalopram and 7 days of citalopram (Harmer et al. 2006; Del-Ben et al. 2005; Murphy et al. 2009;…”
BackgroundEscitalopram Decreases Cross-Regional Functional Connectivity within the Default-Mode Network
van de Ven, V., Wingen, M., Kuypers, K. P. C., Ramaekers, J. G., & Formisano, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068355 · Cited by 65
“Specifically, escitalopram has been found to decrease brain activity in medial cortical and hippocampal areas during task executions [31,33,34].”
BackgroundKleyn, C. E., McKie, S., Ross, A. R., Montaldi, D., Gregory, L. J., Elliott, R., Isaacs, C. L., Anderson, I. M., Richards, H. L., Deakin, J. F. W., et al. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.152 · Cited by 73
Self-citationSerotonergic and Noradrenergic Modulation of Emotion Processing by Single Dose Antidepressants
Brühl, A. B., Kaffenberger, T., & Herwig, U. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.159 · Cited by 73
“In a study of Del-Ben et al, 2005 , subjects performed three tasks addressing behavioral inhibition, reinforcement processing, and covert emotional face recognition after infusion of citalopram.”
Gruber, S. A., Sagar, K. A., Dahlgren, M. K., Gönenç, A., Smith, R. T., Lambros, A. M., Cabrera, K. B., & Lukas, S. E. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00983 · Cited by 66
“In fact, several studies have shown that mood stabilizers, benzodiazepines, and antidepressants generally attenuate activation (Bell et al., 2005; Del-Ben et al., 2005; Paulus et al., 2005; Arce et al., 2008; Murphy et al., 2009).”
BackgroundChantiluke, K., Barrett, N., Giampietro, V., Santosh, P., Brammer, M., Simmons, A., Murphy, D. G., & Rubia, K. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3837-2 · Cited by 63
“The upregulation effect of fluoxetine on right IFC and left OFC-striatal regions in ADHD extends prior evidence on SE agonist modulation of these areas in healthy adults during inhibitory control (Del-Ben et al. 2005) to the ADHD population.”
ResultRoberts, C., Sahakian, B. J., & Robbins, T. W. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.001 · Cited by 65
Superior face recognition in Body Dysmorphic Disorder
Jefferies, K., Laws, K. R., & Fineberg, N. A. (2012) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2012.03.002 · Cited by 62
“Studies have reported attenuated behavioural and brain (amygdala) responses in healthy controls to aversive stimuli such as negative facial emotions after acute single-dose (but not chronic) SSRI administration (Del-Ben et al., 2005; Anderson et al., 2007; Bigos et al., 2008; Murphy, Norbury, O’Sullivan, Cowen, & Harm…”
Vӧllm, B., Richardson, P., McKie, S., Reniers, R. L. E. P., Elliott, R., Anderson, I. M., Williams, S., Dolan, M., & Deakin, J. F. W. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.07.005 · Cited by 68
Self-citationBermpohl, F., Walter, M., Sajonz, B., Lücke, C., Hägele, C., Sterzer, P., Adli, M., Heinz, A., & Northoff, G. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.07.061 · Cited by 66
Antidepressants for neuroenhancement in healthy individuals: a systematic review
Repantis, D., Schlattmann, P., Laisney, O., & Heuser, I. (2008) · Poiesis & Praxis · doi:10.1007/s10202-008-0060-4 · Cited by 65
Bernasconi, F., Schmidt, A., Pokorny, T., Kometer, M., Seifritz, E., & Vollenweider, F. X. (2014) · Cerebral Cortex · doi:10.1093/cercor/bht178 · Cited by 60
“For instance, causing a reduced neural response to fearful faces within the amygdala, parahippocampal, and medial prefrontal cortex (Del-Ben et al. 2005; Harmer et al. 2006; Anderson et al. 2007; Norbury et al. 2007; Murphy et al. 2009).”
BackgroundCognitive remediation in the treatment of stimulant abuse disorders: A research agenda.
Vocci, F. J. (2008) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0014101 · Cited by 68
Metadata
- Authors
- Del-Ben, C. M., Deakin, J. F. W., Mckie, S., Delvai, N. A., Williams, S. R., Elliott, R., Dolan, M., & Anderson, I. M.
- Affiliations
- University of Manchester (GB)
- Corresponding author
- Anderson, Ian M
- Venue
- Neuropsychopharmacology
- Published
- 2005-04-13
- Volume
- 30
- Issue
- 9
- Pages
- 1724-1734
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2104461993
- Cited by
- 260
- References
- 88
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 10 · 2020: 12 · 2019: 7 · 2018: 7 · 2017: 8 · 2016: 9 · 2015: 18 · 2014: 22 · 2013: 21 · 2012: 16
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Medical Research Council
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- citalopram, serotonin, go/no-go task, loss aversion, emotion recognition, orbitofrontal cortex, amygdala, impulsivity, drug challenge
- MeSH terms
- Adult, Brain Mapping, Cerebral Cortex, Decision Making, Humans, Image Processing, Computer-Assisted, Functional Laterality, Magnetic Resonance Imaging, Male, Neuropsychological Tests, Oxygen, Pattern Recognition, Visual, Citalopram, Single-Blind Method, Cross-Over Studies, Antidepressive Agents, Second-Generation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.